Lecanemab treatment modulates brain volume and cerebrospinal fluid pathways in early Alzheimer's disease: Insights from longitudinal magnetic resonance imaging (Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2026)